Puma Historical Cash Flow
| PBYI Stock | USD 2.97 0.05 1.66% |
Analysis of Puma Biotechnology cash flow over time is an excellent tool to project Puma Biotechnology future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Operating Activities of 32.6 M or Net Income of 20.4 M as it is a great indicator of Puma Biotechnology ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Puma Biotechnology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Puma Biotechnology is a good buy for the upcoming year.
Puma |
About Puma Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Puma balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Puma's non-liquid assets can be easily converted into cash.
Puma Biotechnology Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Puma Biotechnology's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Puma Biotechnology current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.As of now, Puma Biotechnology's Net Income is increasing as compared to previous years. The Puma Biotechnology's current Total Cashflows From Investing Activities is estimated to increase to about 8.6 M, while Change In Cash is projected to decrease to under 4.1 M.
Puma Biotechnology cash flow statement Correlations
Click cells to compare fundamentals
Puma Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Puma Biotechnology cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 24.2M | (22.2M) | 3.5M | 7.9M | 7.1M | 4.1M | |
| Free Cash Flow | (19.2M) | 20.7M | (22.8M) | 14.4M | 12.9M | 13.6M | |
| Change In Working Capital | 13.2M | (602K) | (43.6M) | (17.9M) | (16.1M) | (15.3M) | |
| Other Cashflows From Financing Activities | 68K | (30.4M) | (277K) | (19.1M) | (17.2M) | (16.4M) | |
| Other Non Cash Items | 1.0M | 7.2M | 7.0M | 1.5M | 1.7M | 1.6M | |
| Capital Expenditures | 20.0M | 1K | 7M | 12.6M | 14.5M | 15.3M | |
| Total Cash From Operating Activities | 800K | 20.7M | (15.8M) | 27.0M | 31.1M | 32.6M | |
| Net Income | (60.0M) | (29.1M) | 2K | 21.6M | 19.4M | 20.4M | |
| Total Cash From Financing Activities | 100K | (31.9M) | 12.2M | 2.4M | 2.2M | 2.1M | |
| End Period Cash Flow | 97.5M | 75.3M | 78.8M | 86.7M | 99.7M | 71.5M | |
| Begin Period Cash Flow | 73.2M | 97.5M | 75.3M | 78.8M | 90.6M | 70.0M | |
| Sale Purchase Of Stock | 7.7M | 1.4M | 68K | 12.2M | 11.0M | 10.5M | |
| Change To Inventory | (284K) | (3.7M) | 2.6M | (2.6M) | (2.3M) | (2.2M) | |
| Total Cashflows From Investing Activities | 5.2M | 23.4M | (10.9M) | 7.1M | 8.2M | 8.6M | |
| Depreciation | 10.0M | 10.6M | 8.9M | 11.5M | 13.2M | 13.9M | |
| Cash And Cash Equivalents Changes | (39.5M) | 24.2M | (22.2M) | 3.5M | 3.2M | 5.0M | |
| Cash Flows Other Operating | 10.9M | (1.1M) | 4.7M | (536K) | (616.4K) | (585.6K) | |
| Change To Account Receivables | 2.4M | (6.0M) | (7.8M) | (8.4M) | (7.5M) | (7.2M) | |
| Other Cashflows From Investing Activities | (306K) | (20.1M) | (19K) | (12.5M) | (14.4M) | (15.1M) | |
| Change To Netincome | 66.6M | 37.6M | 39.8M | 18.8M | 21.7M | 20.6M | |
| Change To Liabilities | 21.1M | 12.1M | (902K) | (37.8M) | (34.0M) | (32.3M) | |
| Change Receivables | (8.1M) | 2.4M | (6.0M) | (7.8M) | (7.0M) | (6.7M) | |
| Stock Based Compensation | 36.6M | 32.6M | 11.8M | 10.2M | 9.2M | 8.8M | |
| Investments | 43.4M | (10.9M) | 14.1M | (22.8M) | (26.3M) | (24.9M) | |
| Change To Operating Activities | 33.5M | 18.2M | 9.9M | (33.6M) | (30.2M) | (28.7M) |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.417 | Earnings Share 0.46 | Revenue Per Share | Quarterly Revenue Growth 0.435 | Return On Assets |
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.